The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis. Safipour Z, van der Zanden R, van den Bergh J, Janssen P, et al. Osteoporos Int 2021 Oct 3. pii: 10.1007/s00198-021-06101.

Read + Share

Amedeo Smart

Independent Medical Education

Safipour Z, van der Zanden R, van den Bergh J, Janssen P, et al. The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis. Osteoporos Int 2021 Oct 3. pii: 10.1007/s00198-021-06101.
PMID: 34601629